De novo design of quinazoline derivatives as CDK2 inhibitors: 3D-QSAR, molecular fragment replacement and Volsurf predictions
De novo design of quinazoline derivatives as CDK2 inhibitors: 3D-QSAR, molecular fragment replacement and Volsurf predictions
复制标题
作为 CDK2 抑制剂的喹唑啉衍生物的从头设计:3D-QSAR、分子片段替换和 Volsurf 预测
DOI:
10.1080/08927022.2011.563302
复制
发表时间:
2011-08
影响因子:
2.1
通讯作者:
Zhang, Wei-Wei
中科院分区:
文献类型:
--
作者:
Wang, Jian;Leng, Ying;Lu, Tao;Chen, Ya-Dong;Liu, Hai-Chun;Lin, Guo-Wu;Yang, Tao-Tao;Yuan, Hao-Liang;Ran, Ting;Lu, Shuai;Zhang, Wei-Wei
Cyclin-dependent kinase 2 (CDK2) has appeared as an important drug target over the years with a multitude of therapeutic potentials. To design compounds with enhanced inhibitory potencies against CDK2, 3D-QSAR and molecular fragment replacement studies were performed on the pyrazolo[4,3-h]quinazoline derivatives, a class of potent CDK2 inhibitors. The contours of 3D-QSAR model revealed important structural features of the inhibitors related to the active site of CDK2. Based on the pyrazolo[4,3-h]quinazoline core, the different substituents at three important points were replaced with diverse molecular fragments. The compounds resulting from fragments assembly with pyrazolo[4,3-h]quinazoline core were then scored with the robust 3D-QSAR model. Furthermore, the absorption, distribution, metabolism and excretion properties of these compounds were predicted by Volsurf to eliminate inappropriate compounds. Thirty-one new potential compounds were finally obtained. These results initiated us to further optimise and design new potential inhibitors.
登录
查看更多内容
影响因子:
3.4
作者:
R. Rao
通讯作者:
R. Rao
影响因子:
4.6
作者:
Cruciani, G;Pastor, M;Guba, W
通讯作者:
Guba, W
DOI:
--
发表时间:
2013
期刊:
--
影响因子:
--
作者:
P. Labute
通讯作者:
P. Labute
影响因子:
120.1
作者:
Siân Renfrey;Christian Downton;James Featherstone
通讯作者:
Siân Renfrey;Christian Downton;James Featherstone
影响因子:
3
作者:
T. Halgren;R. Nachbar
通讯作者:
T. Halgren;R. Nachbar